Mobile messaging company Tango is announcing some new additions to its Channels program for publishers and brands, including BuzzFeed and Vimeo. As I wrote when the program launched in June, Tango’s ...
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that ...
– The phase 1/2 clinical trial of TNG348, a USP1 inhibitor, is being terminated due to toxicity observed in the initial study cohorts – – Cash runway extended into 2027, PRMT5 and CoREST clinical ...
For its season closer Symphony Silicon Valley didn’t decide to just spice up its program with a little tango. In deepening the ensemble’s relationship with Argentine conductor Carlos Vieu and his ...
BOSTON, May 23, 2024--(BUSINESS WIRE)--Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback